2nd Quarter - Report

GREENWICH BIOSCIENCES, INC. for GREENWICH BIOSCIENCES, INC.

Firm
Client
Income
—
Expenses
$60,000
Expense method
A: Lobbying Disclosure Act definitions

What was lobbied

One issue area, each in the filer's own words, with who lobbied on it and where.

Health Issues HCR

Introduction of company and development of a FDA approved cannabinoid drug H.R. 2 - Agriculture Improvement Act of 2018 - FDA's jurisdiction over hemp-derived CBD products

LobbyistCovered position, as disclosed
ALICE P. MEAD —

Contacted: Drug Enforcement Administration (DEA); HOUSE OF REPRESENTATIVES; SENATE

Bills named: H.R. 2 (115th)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.